Posts

Showing posts with the label Radiopharmaceutical

Rise In Demand : Radiopharmaceutical Market in Global Industry Trends and Forecast 2018-2024| Mallinckrodt PLC, Nordion, Siemens Healthineers and Positron Corporation

ResearchMoz presents professional and in-depth study of "Radiopharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024". This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development of new sources for radioisotope production, and rise in demand for nuclear medicine are boosting the radiopharmaceutical market. Increase in incidence of cancer and cardiovascular diseases, growth in awareness about effective use of radiopharmaceuticals, and rise in preference for SPECT and PET scans are some of the factors expected to drive the growth of the global radiopharmaceutical market during the forecast period. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=139214 The radiopharmaceutical market report comprises an elaborate executive summary, which includes market snapshot...

Growth Opportunities Of Radiopharmaceutical Market in Global Industry 2018-2025| Navidea, Dongcheng, SIEMENS And Advanced Accelerator Applications

ResearchMoz presents professional and in-depth study of "Global Radiopharmaceutical Market Professional Survey Report 2018". This report studies the global Radiopharmaceutical market status and forecast, categorizes the global Radiopharmaceutical market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1847215 Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. ...